Notícias

Em 10 de julho, a Lepu Medical divulgou a pré-anúncio dos lucros do primeiro semestre de 2017, esperava um lucro líquido de 491 milhões a 528 milhões de CNY. Comparando com 377 milhões de CNY para o mesmo período do ano passado, a taxa de crescimento ano a ano atingiu até 30% - 40%.

A empresa alegou que as previsões acima referidas foram feitas pelas seguintes razões:

1.During the first half of 2017, the company's business continued the growth trend of the first quarter. For the category of medical devices, the business of coronary stents, primary hospitals, in vitro diagnostic and surgical products maintain the rapid increase, as well as the category of pharmaceuticals. At the same time, with the continuous expansion of Lepu’s business scale, the financial expenses increased significantly compared to the same period last year.

Espera-se que o lucro líquido atribuível aos acionistas aumente de 30% a 40% em relação ao mesmo período do ano passado.

2.During the first half of 2017, the company's non-recurring profit and loss were approximately 7 million CNY, which had no significant impact on the company's profitability during the reporting period.